PMID- 36466832 OWN - NLM STAT- MEDLINE DCOM- 20221206 LR - 20221206 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 13 DP - 2022 TI - Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018. PG - 1058779 LID - 10.3389/fimmu.2022.1058779 [doi] LID - 1058779 AB - BACKGROUND: As a novel inflammatory marker, Systemic Immune-Inflammation Index (SII) has not been studied with hepatic steatosis. The aim of this study was to investigate the possible relationship between SII and hepatic steatosis. METHODS: In the cross-sectional investigation, adults having complete information on SII, hepatic steatosis, and bariatric surgery from the 2015-2018 National Health and Nutrition Examination Survey (NHANES) were included. Hepatic steatosis was evaluated with heaptic steatosis index (HSI). The platelet count x neutrophil count/lymphocyte count was used to compute SII. We investigated the independent interaction between SII and hepatic steatosis using weighted multivariable regression analysis and subgroup analysis. To explore the potential relationship between SII, bariatric surgery and hepatic steatosis by controlling potential confounders by propensity score matching. RESULTS: The study involved 10505 participants in total, 5937 (56.5%) of whom had hepatic steatosis according to the diagnosis. After adjusted for covariates, multivariable logistic regression revealed that high SII level was an independent risk factor for hepatic steatosis (OR = 1.30, 95% CI: 1.10-1.52, P 0.01). Unexpectedly, bariatric surgery reduced SII even after PSM corrected for differences of BMI and HSI. CONCLUSIONS: In US adults, SII was positively correlated with an increase in hepatic steatosis. The SII may be a simple and affordable way to identify hepatic steatosis. Bariatric surgery may reduce SII without resorting to weight loss. This needs to be verified in additional prospective research. CI - Copyright (c) 2022 Song, Guo, Li, Guo, Li and Li. FAU - Song, Yancheng AU - Song Y AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Guo, Wencong AU - Guo W AD - Laboratory of Nephrology & Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Li, Zhaopeng AU - Li Z AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Guo, Dong AU - Guo D AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Li, Zhao AU - Li Z AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. FAU - Li, Yu AU - Li Y AD - Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. LA - eng PT - Journal Article DEP - 20221118 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 SB - IM MH - Adult MH - Humans MH - Nutrition Surveys MH - Cross-Sectional Studies MH - Prospective Studies MH - *Fatty Liver MH - Inflammation PMC - PMC9718528 OTO - NOTNLM OT - NHANES OT - bariatric surgery OT - hepatic steatosis OT - non-alcoholic fatty liver disease OT - systemic immune-inflammation index (SII) COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/12/06 06:00 MHDA- 2022/12/07 06:00 PMCR- 2022/01/01 CRDT- 2022/12/05 04:12 PHST- 2022/09/30 00:00 [received] PHST- 2022/11/08 00:00 [accepted] PHST- 2022/12/05 04:12 [entrez] PHST- 2022/12/06 06:00 [pubmed] PHST- 2022/12/07 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2022.1058779 [doi] PST - epublish SO - Front Immunol. 2022 Nov 18;13:1058779. doi: 10.3389/fimmu.2022.1058779. eCollection 2022.